Sponsor:
Baycrest
Code:
NCT07291687
Conditions
Progressive Supranuclear Palsy
Cortical Basal Ganglionic Degeneration
Parkinson Disease
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Interventions
Transcranial direct current stimulation (TDCS)
Stimulation Arm
Brief summary:
Conditions
Progressive Supranuclear Palsy
Cortical Basal Ganglionic Degeneration
Parkinson Disease
Study ID
NCT07291687
Start date
Oct 30, 2025
Status verified date
Dec, 2025
Completion date
Dec, 2030
Anticipated
Primary completion date
Dec, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
20 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
experimental: Real tDCS Stimulation:
placebo comparator: Sham Arm
Interventions
Transcranial direct current stimulation (TDCS)
Stimulation Arm
Primary outcome measure
Central contacts
Locations
Baycrest Academy of Health Sciences and Geriatric Research
Recruiting
Toronto, Ontario, Canada, M6A 2E1
Sponsor
Baycrest
Last update posted
Dec 18, 2025
Last verified
Dec, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Baycrest on 2025-12-18.